Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection
about
DENV inhibits type I IFN production in infected cells by cleaving human STINGZ proteins of New World arenaviruses bind RIG-I and interfere with type I interferon inductionHepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunityHepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferonHepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell linesInhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virusY-box-binding protein 1 interacts with hepatitis C virus NS3/4A and influences the equilibrium between viral RNA replication and infectious particle productionModulation of the type I interferon pathways by culture-adaptive hepatitis C virus core mutantsRegulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanismsInhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complexReplication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122Function and regulation of retinoic acid-inducible gene-IInnate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNAIdentification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virusGB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVSThe Dual Role of Exosomes in Hepatitis A and C Virus Transmission and Viral Immune ActivationRegulation of hepatic innate immunity by hepatitis C virusImmune responses to HCV and other hepatitis virusesMDA5 and LGP2: accomplices and antagonists of antiviral signal transductionInnate immune responses in hepatitis C virus infectionTLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetesReplication of Hepatitis C Virus (HCV) RNA in Mouse Embryonic Fibroblasts: Protein Kinase R (PKR)-Dependent and PKR-Independent Mechanisms for Controlling HCV RNA Replication and Mediating Interferon ActivitiesHepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expressionResistance to Alpha/Beta Interferon Is a Determinant of West Nile Virus Replication Fitness and VirulenceRegulation of CXCL-8 (Interleukin-8) Induction by Double-Stranded RNA Signaling Pathways during Hepatitis C Virus InfectionThe Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host CellsHepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteinsHepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal HepatocytesDisruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursorCapsid Protein of Eastern Equine Encephalitis Virus Inhibits Host Cell Gene ExpressionThe C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral ReplicationUbiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virusHepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human HepatocytesHepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase LDistinct RIG-I and MDA5 Signaling by RNA Viruses in Innate ImmunityEstablishment and Maintenance of the Innate Antiviral Response to West Nile Virus Involves both RIG-I and MDA5 Signaling through IPS-1Agonist and Antagonist Recognition by RIG-I, a Cytoplasmic Innate Immunity ReceptorHCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA MiceCleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes
P2860
Q21131391-883BAE3E-CB53-477E-B3D5-E97960239524Q22001518-F91399E4-5DE5-4780-B21A-F4B052EB84ACQ24297286-BECD94D0-D2F0-4882-968E-7A9F5E38FC8BQ24306639-BF7C8F1D-3098-4F32-9A71-8EC4002CC39CQ24310415-A0E1A0F4-1641-4A21-A065-46AB5231DBD0Q24311228-EF938E54-451C-4F52-90BA-9D802A1984D7Q24323080-4AABFA01-2D3F-46F5-9F6C-08EC01359C60Q24329074-D1CF72E9-FA56-4CCE-AAE7-5AE11569A6C3Q24338327-DE604C86-C615-4CBB-9206-C4481303043DQ24548483-A0FC6CF2-8CFE-46F3-9716-4C8C73BED562Q24611465-11FB97CF-8BE7-46C7-A611-1193A1228490Q24611792-71D72E0F-AD44-4399-9FB0-32930CF8ED21Q24632537-9C606D37-B028-4AC3-9BCF-7FE1AC2C28E0Q24634416-918495EF-01B3-4E14-9E5B-79B12F3A956EQ24658111-A692C6C6-502C-4D4B-9E63-346A9BF53C13Q24675888-93CCB04C-31F0-4D7A-98F4-E9CDF4CD7894Q26773325-F6362500-D104-40C2-B40E-7946D9CF4C33Q26824743-4C8F055C-D126-4163-92AF-D02674EE20B4Q26866955-E2954809-0697-43C2-A982-E28B78CDBAFCQ27010611-AC16F074-C358-4B9A-B91F-9E362848A8CCQ27023055-578E5BE0-205B-4EB1-B784-BB49C4C4F6BFQ27025559-DAF3AEBD-989B-423C-BFCF-91FB961A7427Q27477459-30A778D4-560B-42FE-B25F-F8A9A00AA3E0Q27477482-AC95AE29-E979-40AB-BBE9-CC4F37E5603CQ27477539-9C822C9A-BF7B-49B2-BFCD-DB9C91759392Q27478028-3DB44322-DB4B-4F51-8D33-701F80F2799CQ27478044-FF6B658B-9FF0-46D7-B4E9-B62A3A70A55AQ27478188-86C413D1-5CC3-44D3-A398-9FC24E2AD52FQ27478288-E51DF92A-D1E3-44BF-A58D-65601598B023Q27478302-90B72AD3-AF9F-45B6-BDA8-3DF85207118FQ27478382-C4150552-0BFE-4730-83FE-FE341B376D20Q27481029-4394F96F-116C-4395-AB0B-40811B37F9A0Q27481222-1E4962C7-3D47-4BF6-9DA4-6C14B4B64AD8Q27485023-B23AC69C-AC19-48A1-8BA1-B3AA96E5B44BQ27485064-7BFBF15A-EFA0-4EF8-8642-605B75121455Q27485306-A6822902-536C-4B0A-964C-1071213DBBBFQ27485316-D68BCD19-310C-4306-8ED3-0906E0C343C4Q27487543-6678D51E-B9C1-4B36-8595-FE3CB7B962E8Q27487963-15514D0E-61EA-4704-9C67-5C3523FABB3EQ27487969-D78BA973-DDC3-49D3-BF8D-FCD313A3FD00
P2860
Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Viral and therapeutic control ...... ng hepatitis C virus infection
@ast
Viral and therapeutic control ...... ng hepatitis C virus infection
@en
Viral and therapeutic control ...... ng hepatitis C virus infection
@nl
type
label
Viral and therapeutic control ...... ng hepatitis C virus infection
@ast
Viral and therapeutic control ...... ng hepatitis C virus infection
@en
Viral and therapeutic control ...... ng hepatitis C virus infection
@nl
prefLabel
Viral and therapeutic control ...... ng hepatitis C virus infection
@ast
Viral and therapeutic control ...... ng hepatitis C virus infection
@en
Viral and therapeutic control ...... ng hepatitis C virus infection
@nl
P2093
P2860
P50
P3181
P356
P1476
Viral and therapeutic control ...... ng hepatitis C virus infection
@en
P2093
Andrea K Erickson
Curt H Hagedorn
Cynthia L Johnson
D Spencer Carney
Daryl T-Y Lau
Hisashi Ishida
Penny M Fish
Stanley M Lemon
Steven A Weinman
P2860
P304
P3181
P356
10.1073/PNAS.0601523103
P407
P577
2006-04-11T00:00:00Z